CBD suppressed osteosarcoma cell growth and tumor formation in mice by directly binding to NF-kB and disrupting the TNF-alpha/NF-kB/CCL5 inflammatory signaling axis.
Cancer researchers, oncologists following cannabinoid research, and anyone interested in CBD's potential anti-cancer mechanisms beyond anecdotal claims.
What the researchers found
CBD directly binds the NF-kB subunit p65, disrupting a positive feedback loop between NF-kB and CCL5 that drives osteosarcoma inflammation and proliferation. This was validated in both cell culture and mouse tumor models.
Why it matters
Osteosarcoma is an aggressive bone cancer with limited treatment options. Identifying that CBD targets a specific inflammatory pathway provides a mechanistic rationale for further investigation, beyond general anti-cancer claims.
The numbers in context
CBD suppressed proliferation (EdU assay), migration, and invasion in cell culture. Inhibited xenograft tumor growth in vivo. Molecular binding to p65 confirmed by four complementary methods.
How the study worked
Comprehensive preclinical study using cell viability assays, functional assays (proliferation, migration, invasion), mouse xenograft tumors, network pharmacology, RNA-seq, and molecular binding confirmation (CETSA, SPR, ITC, molecular docking).
What this study cannot tell us
Preclinical only — mouse xenograft models don't fully replicate human bone cancer. CBD concentrations used may not be achievable in human patients. Single cancer type studied.
How to read the evidence
Thorough preclinical investigation with multiple validation methods, but remains far from clinical application.
When this study was published
Recent study providing the first evidence of CBD targeting the TNF-alpha/NF-kB/CCL5 axis in osteosarcoma.
The bigger picture
Anti-cancer claims for CBD are common but often lack mechanistic evidence. This study provides the first detailed molecular mechanism for CBD's effects on osteosarcoma, moving beyond 'CBD kills cancer cells' to identifying exactly how and where it acts.
Questions still open
- Could CBD enhance existing osteosarcoma treatments as a combination therapy? Would the NF-kB-targeting mechanism apply to other cancers driven by this inflammatory pathway?
Common questions
Can CBD treat bone cancer?
How does CBD target cancer cells?
Read the original research
Antitumor effects of cannabidiol (CBD) on osteosarcoma by targeting TNF-α/NF-κB/CCL5 signaling axis.
Phytomedicine : international journal of phytotherapy and phytopharmacology, 145, 157066
Citation
Yang, Fan; Duan, Shuqin; Liu, Jingwei; An, Zhechao; Liu, Wangyang; Wang, Xinyue; Zhang, Tingting; Liu, Mingyu; Li, Fengda; Wu, Wei; Liu, Yingzhe; Tang, Jianyong; Wang, Xiaojuan; Xu, Wenhui; Qi, Wenyi; Liu, Yunhe; Li, Liangliang; Li, Yuan; Liu, Xin; Yang, Baofeng; Zhang, Zheng; Wang, Li; Yang, Lei. (2025). Antitumor effects of cannabidiol (CBD) on osteosarcoma by targeting TNF-α/NF-κB/CCL5 signaling axis.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 145, 157066. https://doi.org/10.1016/j.phymed.2025.157066
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk